Echocardiography Report Analysis - Patient Mathew, 93-year-old Male (KIMSHEALTH, 05/08/2026)

ECHO VALUES SUMMARY

DIAGNOSES (from Report Findings)

• Mild Aortic Stenosis (AS): AV maxPG 33 mmHg, meanPG 18 mmHg - fits mild AS by gradient criteria
• Mild-Moderate Aortic Regurgitation (AR): AR PHT 476 ms (longer PHT = milder AR), AR Vmax 4.94 m/s
• This is a "mixed aortic valve disease" pattern, typical of calcific degeneration in an elderly patient

• 2 jets noted; low-moderate severity
• LA dilated (4.0 cm) - likely consequent to chronic MR and/or elevated filling pressures

• TR maxPG 54.17 mmHg - this estimates RVSP at approximately 59 mmHg (54 + 5 assumed RAP), indicating moderate pulmonary arterial hypertension (PAH)

• RVSP ~59 mmHg (derived from TR gradient)
• Likely secondary (Group 2 PH) from left-sided valvular disease (MR + AS/AR complex)

• EF 65%, No RWMA - preserved LV function, which is favorable

• LA/Ao ratio 1.19, LA diam 4.0 cm - borderline dilated, raising concern for paroxysmal AF

• This is notably high - may represent AF with rapid ventricular response, sinus tachycardia, or arrhythmia at time of study; needs ECG correlation

CLINICAL INTERPRETATION

• Preserved LV systolic function (good prognostic sign)
• Mixed calcific aortic valve disease (mild AS + mild-moderate AR)
• Moderate MR (2 jets)
• Secondary pulmonary hypertension from left-sided lesions
• Possible atrial dilation predisposing to AF (HR 163 on echo is a red flag)

TREATMENT PLAN

A. Immediate Priority - Tachycardia (HR 163 BPM)

• Obtain 12-lead ECG immediately to determine rhythm (AF vs sinus tach vs flutter)
• If AF with rapid ventricular response: Rate control with beta-blocker (bisoprolol 2.5 mg OD, titrated) or digoxin (preferred in elderly with borderline hemodynamics); consider anticoagulation (DOAC preferred - apixaban 2.5 mg BD in elderly >80 years per ARISTOTLE criteria)
• If sinus tachycardia: Identify and treat the underlying cause (pain, fever, anemia, thyrotoxicosis, dehydration)
• Avoid digoxin toxicity given age 93 - check renal function before initiating

B. Aortic Valve Disease (Mild AS + Mild-Moderate AR)

• Currently mild - no surgery indication at this severity
• Medical therapy for AR: vasodilators (nifedipine or ACE inhibitor) to reduce afterload and regurgitant fraction - this improves symptoms and forward stroke volume
• Important caveat: vasodilator therapy provides symptomatic relief but does not eliminate the need for eventual valve intervention (Bailey & Love's Surgery, p. 3688)
• Serial echocardiography every 12 months to track LV dimensions and EF trend
• Watch for triggers for surgical/transcatheter intervention: LV end-systolic diameter >50 mm, EF drop below 50%, symptom onset

C. Mitral Regurgitation (Low-Moderate, 2 Jets)

• At low-moderate severity with preserved EF (65%) and no severe symptoms, no intervention indicated currently
• No vasodilator benefit in normotensive patients with primary MR and preserved EF (meta-analysis showed only ~8% reduction in regurgitant fraction with ACE-I/ARBs, no clinical outcome benefit)
• Treat any hypertension aggressively - BP reduction decreases MR severity
• If severe MR develops: Transcatheter edge-to-edge repair (MitraClip/PASCAL) is appropriate for a 93-year-old deemed high surgical risk

D. Pulmonary Hypertension (Secondary, Group 2)

• This is driven by left-sided valvular disease - treating PAH-specific drugs (sildenafil, bosentan) is NOT indicated for Group 2 PH and may be harmful
• Manage the underlying MR and aortic valve disease to reduce elevated filling pressures
• Diuretics (furosemide 20-40 mg OD) if there is evidence of fluid retention or pulmonary congestion
• Monitor: RVSP trend on serial echo

E. General Cardioprotective Measures

WAY FORWARD

1. ECG today to define the tachycardia rhythm (priority)
2. Blood tests: BMP/renal function, BNP/NT-proBNP, CBC, TFTs (rule out thyrotoxicosis causing tachycardia), HbA1c
3. Start rate control if AF confirmed
4. Consider cardiology/HF specialist review for this complex multi-valvular elderly patient

1. Optimize medical therapy (ACE-I, diuretics as needed)
2. Assess functional status - NYHA class, 6-minute walk test
3. Formal Heart Team discussion if symptoms worsen (dyspnea, syncope, chest pain) - to consider TAVR (Transcatheter Aortic Valve Replacement) if AS/AR progresses, or MitraClip for MR

1. Repeat echo in 12 months (or sooner if clinical deterioration)
2. Monitor LV dimensions (LVIDd, LVESD), EF trend, RVSP
3. Watch for AF if LA continues to dilate
4. Goals of care discussion given age 93 - patient/family preferences about invasive intervention vs. comfort-focused management should be explicitly documented

Key Alert

HR of 163 BPM recorded during this echo is a significant finding that needs same-day ECG assessment. In a 93-year-old with multi-valvular disease, sustained tachycardia - especially AF with rapid ventricular response - can precipitate acute decompensation. This is the most time-sensitive issue in this report.